HL
ARKG icon

HeadInvest LLC’s ARK Genomic Revolution ETF ARKG Stock Holding History

HeadInvest LLC’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-285
Closed -$7.68K – 256
2023
Q3 		$7.68K Buy
+285
New +$9.32K ﹤0.01% 584

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
MM
Main Management San Francisco, California $1.37B AUM 19.06% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

HeadInvest LLC's ARKG Position: Q4 2023 in Review

HeadInvest LLC sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2023, closing a stake of 285 shares — an estimated $7.68K sold.

HeadInvest LLC first reported a position in ARKG in Q3 2023 and held it in 1 quarter. The position peaked at $7.68K in Q3 2023. 298 funds tracked by Wall St. Rank hold ARKG as of Q4 2023.

  • HeadInvest LLC reported no remaining ARK Genomic Revolution ETF position as of Q4 2023 after selling out during the quarter.
  • HeadInvest LLC sold 285 ARK Genomic Revolution ETF shares in Q4 2023, an estimated $7.68K.
  • HeadInvest LLC first reported a position in ARK Genomic Revolution ETF in Q3 2023 and held it in 1 quarter.
  • HeadInvest LLC's ARK Genomic Revolution ETF position peaked at $7.68K in Q3 2023.
  • 298 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2023.

Based on HeadInvest LLC's 13F filing for Q4 2023, filed 12 Feb 2024.